Ling-Yao Kong (Lingyao Kong)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Rheumatoid Arthritis

Tyrosine Kinase

Cardiovascular Risk Factors

Top Venues

Oxidative medicine and cellular longevity

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Yao, Ling-Yao Kong, Chun-Lei Yang, Jiaqi Du, Guojun Zhao, Yapeng Li
Tumor Necrosis Factor- α -Induced Protein 8-Like 2 Ameliorates Cardiac Hypertrophy by Targeting TLR4 in Macrophages. Oxidative medicine and cellular longevity 2022 (2022)
Ling-Yao Kong, Cui Liang, Peng-Cheng Li, Yi-Wei Zhang, Sheng-Dong Feng, Dian-Hong Zhang, Rui Yao, Lu-Lu Yang, Zheng-Yang Hao, Hao Zhang, Xiao-Xu Tian, Chen-Ran Guo, Bin-Bin Du, Chunguang Qiu, Yan-Zhou Zhang
Myotubularin-Related Protein14 Prevents Neointima Formation and Vascular Smooth Muscle Cell Proliferation by Inhibiting Polo-Like Kinase1. Journal of the American Heart Association 11 (21) (2022)